KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 249 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,357,496 | +18.3% | 24,706 | -0.9% | 0.24% | +9.5% |
| Q1 2023 | $4,529,375 | -7.6% | 24,936 | 0.0% | 0.22% | -13.3% |
| Q4 2022 | $4,899,924 | +93.7% | 24,936 | +121.7% | 0.26% | +81.6% |
| Q3 2022 | $2,530,000 | -19.3% | 11,246 | -53.0% | 0.14% | +22.6% |
| Q4 2021 | $3,137,000 | – | 23,950 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $104,312,000 | 36.87% |
| Sofinnova Investments, Inc. | 1,953,077 | $238,920,000 | 14.15% |
| Nan Fung Group Holdings Ltd | 234,811 | $28,724,000 | 9.20% |
| Sands Capital Ventures, LLC | 267,895 | $32,772,000 | 4.94% |
| Logos Global Management LP | 460,000 | $56,272,000 | 4.06% |
| DAFNA Capital Management LLC | 74,585 | $9,124,000 | 2.42% |
| First Light Asset Management, LLC | 275,644 | $33,720,000 | 2.22% |
| Eventide Asset Management | 748,000 | $91,503,000 | 1.21% |
| Rock Springs Capital Management LP | 391,917 | $47,943,000 | 1.01% |
| CATALYST PRIVATE WEALTH, LLC | 18,006 | $2,203,000 | 0.94% |